Intracorporeal versus extracorporeal anastomosis for robotic ileocolic resection in Crohn's disease

• Published in: Journal of robotic surgery 2022-06, Vol.16 (3), p.601-609
• Main Authors: Calini, Giacomo, Abdalla, Solafah, Abd El Aziz, Mohamed A., Saeed, Hamedelneel A., D’Angelo, Anne-Lise D., Behm, Kevin T., Shawki, Sherief, Mathis, Kellie L., Larson, David W.
• Format: Article
• Language: English
• Subjects: Abdomen; Antibiotics; Body mass index; Body size; Classification; Colon; Crohn's Disease; Hemoglobin; Laparoscopy; Malnutrition; Medicine; Medicine & Public Health; Minimally Invasive Surgery; Original Article; Proteins; Recovery (Medical); Robotics; Skin; Small intestine; Surgeons; Surgery; Surgical anastomosis; Tumor necrosis factor-TNF; Urology
• ISSN: 1863-2491; 1863-2483; 1863-2491
• DOI: 10.1007/s11701-021-01283-8

To date, there is no cohort in the literature focusing on the impact of the type of anastomosis in robotic ileocolonic resections for Crohn’s Disease (CD). We aimed to compare short-term postoperative outcomes of robotic ileocolic resection for CD between patients who had intracorporeal (ICA) or extracorporeal anastomosis (ECA). We retrospectively included all consecutive robotic ileocolonic resections for CD at our institution between 2014 and 2020. We compared baseline, perioperative characteristics, and postoperative outcomes between ICA and ECA. The analysis included 89 patients: 71% underwent ICA and 29% ECA. Groups were similar in age, sex, body mass index, smoking, CD duration, Montreal classification, surgical history, and previous CD medical treatments. Return to bowel function was achieved sooner in the ICA group (ICA 1.6 ± 0.7 day, ECA 2.1 ± 0.8 days; p  = 0.026) despite longer operative time (ICA 235 ± 79 min, ECA 172 ± 51 min; p